drugset / Trial / NCT05654064

Comparing Fetoscopic Surgery Protocols

NCT05654064 ↗

RandomizedParallel-groupDouble-blindOther

Summary

Determine surgeon and patient satisfaction with remifentanil-dexmedetomidine (REMI) and dexmedetomidine-fentanyl (DEX) sedation protocols in pregnant patients undergoing minimally invasive fetoscopic procedures

Timeline

Start
2022-04
Primary completion
2024-04
Completion
2024-04

Outcome

Outcome not reported

Stopped: “Deferred by IRB.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified — —
Comparator Fentanyl Other / unclassified — —
Comparator Remifentanil Small molecule — —

Indications

No indication recorded.